This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
US veterans and active-duty military deserve the best medical treatments available. DUROLANE for knee OA pain can be part of that solution.
A single-injection hyaluronic acid (HA) therapy for knee osteoarthritis, DUROLANE offers important benefits for treatment of knee OA pain.
Longer-Lasting Knee Pain Relief vs. Steroid11
In a Level 1 study, DUROLANE was proven to be noninferior to steroid at 6 weeks.11
Designed as a Single-Injection Therapy With Unique Stabilizing Technology10
DUROLANE is stabilized using a carefully controlled cross-linking process with greater resistance to degradation, which increases the intra-articular residence time compared to other HA preparations.†
Convenience Without Compromise
DUROLANE is the only FDA approved single-injection HA proven to be equivalent to a five-injection therapy.24,13
In a Level 1 study, one injection of DUROLANE produced pain reduction at 6 months that was noninferior to the relief achieved with five injections of the comparator HA.24
And one injection means only one doctor’s visit.
Endurance by Design
DUROLANE has a half-life of approximately 4 weeks in a human knee joint with a single-injection treatment regimen―as well as the longest reported half-life of any leading HA.†32-35
Disclaimer: Animal performance may not be predictive of performance in humans
How can we help you and your patients?
To learn more about DUROLANE, contact a rep by emailing BioventusIS@Bioventus.com or send your questions to us in the form below.
Disclaimer: Bioventus will never make your email address available to third parties, except to distribute requested materials. Any complaints or adverse reaction messages may be sent to Complaints@Bioventus.com.
†Preclinical residence time has not been correlated with the duration of clinical effect.